[en] OBJECTIVE: To evaluate the place of subtotal hysterectomy during laparoscopic sacrocolpopexy. METHODS: This retrospective observational study includes patients undergoing laparoscopic sacrocolpopexy between November 2010 and March 2015 at the Centre Hospitalier Regional de la Citadelle, Liege, Belgium. Patient characteristics, medical and surgical history were collected. Clinical data, operative and intraoperative complications were analyzed. The postoperative results were collected at 6 weeks, 4 months and then every year with a clinical and anatomical evaluation by POP-Q (Pelvic Organ Prolapse - Quantification). RESULTS: Ninety-four patients were included in the study. Sixty-four patients (68.1%) underwent sacrocolpopexy with subtotal hysterectomy, 12 patients (12.7%) had sacrocolpopexy with uterine preservation, 16 patients (17%) had a clinical history of hysterectomy and 2 patients (2.2%) have had sacrocolpopexy with total hysterectomy. The mean age of the patients was 61+/-20 years, parity 2+/-2 and BMI 25.2+/-7.32. The objective success rate, defined by a stage of POP-Q<2, was 93.75% in the sacrocolpopexy group with subtotal hysterectomy vs. 66.7% in the sacrocolpopexy group with uterine preservation (P=0.019). The subjective success rates were 98.4% and 83% respectively (P=0.063ns). CONCLUSION: Sacrocolpopexy offers good anatomical results, with better objective and subjective success rates when associated with a subtotal hysterectomy. The decision of hysterectomy should consider the risk/benefit balance and the patient's preferences.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Saliba, E.
Nisolle, Michelle ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Tchente, C.
DE LANDSHEERE, Laurent ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Language :
French
Title :
Doit-on realiser systematiquement une hysterectomie subtotale dans le cadre d'une promontofixation coelioscopique ?
Alternative titles :
[en] Do we need to perform systematic supracervical hysterectomy during laparoscopic sacrocolpopexy?
Publication date :
2019
Journal title :
Gynécologie, Obstétrique, Fertilité et Sénologie
ISSN :
2468-7197
eISSN :
2468-7189
Publisher :
Elsevier Masson, Issy-les-Moulineaux, France
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Copyright (c) 2019 Elsevier Masson SAS. All rights reserved.
Khunda, A., Vashisht, A., Cutner, A., New procedures for uterine prolapse. Best Pract Res Clin Obstet Gynaecol 27:3 (2013), 363–379.
Maher, C., Feiner, B., Baessler, K., Schmid, C., Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev, 4, 2013, CD004014.
Deffieux, X., Letouzey, V., Savary, D., Sentilhes, L., Agostini, A., Mares, P., et al. Prevention of complications related to the use of prosthetic meshes in prolapse surgery: guidelines for clinical practice. Eur J Obstet Gynecol Reprod Biol 165 (2012), 170–180.
Tan-Kim, J., Menefee, S.A., Luber, K.M., Nager, C.W., Lukacz, E.S., Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J 22:2 (2011), 205–212.
Korbly, N.B., Kassis, N.C., Good, M.M., Richardson, M.L., Book, N.M., et al. Patient preferences for uterine preservation and hysterectomy in women with pelvic organ prolapse. Am J Obstet Gynecol 209:5 (2013), 470–476.
Dubuisson, J.B., Veit-Rubin, N., Wenger, J.M., Dubuisson, J., La suspension latérale cœlioscopique, une autre façon de traiter les prolapsus génitaux. Gynecol Obstet Fertil Senol 45:1 (2017), 32–36.
Fatton, B., Amblard, J., Jacquetin, B., Is hysterectomy indicated during prolapsus treatment?. Ann Urol (Paris) 41:3 (2007), 91–109.
Good, M.M., Korbly, N., Kassis, N.C., Richardson, M.L., Book, N.M., et al. Prolapse-related knowledge and attitudes toward the uterus in woman with pelvic organ prolapse symptoms. Am J Obstet Gynecol 209:5 (2013), 481–486.
Cayrac, M., Warembourg, S., Le Normand, L., Fatton, B., Does hysterectomy modifies the anatomical and functional outcomes of prolapse surgery?: clinical Practice Guidelines. Prog Urol 26:Suppl 1 (2016), S73–S88.
Farthmann, J., Watermann, D., Erbes, T., Roth, K., Nanovska, P., et al. Functional outcome after pelvic floor reconstructive surgery with or without concomitant hysterectomy. Arch Gynecol Obstet 291:3 (2015), 573–577.
Pan, K., Cao, L., Ryan, N.A., Wang, Y., Xu, H., Laparoscopic sacral hysteropexy versus laparoscopic sacrocolpopexy with hysterectomy for pelvic organ prolapse. Int Urogynecol J 27:1 (2016), 93–101.
Gracia, M., Perelló, M., Bataller, E., Espuña, M., Parellada, M., et al. Comparison between laparoscopic sacral hysteropexy and subtotal hysterectomy plus cervocipexy in pelvic organ prolapse, a pilot study. Neurourol Urodyn 34:7 (2015), 654–658.
Cundiff, G.W., Varner, E., Visco, A.G., Zyczynski, H.M., Nager, C.W., et al. Pelvic Floor Disorders Network. Risk factors for mesh/suture erosion following sacral colpopexy. Am J Obstet Gynecol, 199(6), 2008, 688.
Gutman, R., Maher, C., Uterine-preserving POP surgery. Int Urogynecol J 24:11 (2013), 1803–1813.
Rosati, M., Bramante, S., Conti, F., et al. A review on the role of laparoscopic sacrocervicopexy. Curr Opin Obstet Gynecol 26:4 (2014), 281–289.
Mansoor, A., Campagne, S., Cornou, C., Goujon, N., Cerisier, S., et al. Faut il conserver l'utérus lors de la cure de prolapsus ? Réflexions à partir des résultats anatomo-pathologiques. Gynecol Obstet Fertil 41:2 (2013), 80–84.
Frick, A., Walters, M., Larkin, K., Barber, M., Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse. Am J Obstet Gynecol, 202(5), 2010, 507.
Hill, A.J., Carroll, A.W., Matthews, C.A., Unanticipated uterine pathologic finding after morcellation during robotic-assisted supracervical hysterectomy and cervicosacropexy for uterine prolapse. Female Pelvic Med Reconstr Surg 20:2 (2014), 113–115.
George, S., Barysauskas, C., Serrano, C., Oduyebo, T., Rauh-Hain, J.A., et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer 120:20 (2014), 3154–3158.